Interleukin-1 receptor (Immunex)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterleukin-1 receptor (Immunex)
Drug Alias NameIL-1RI - AmgenSoluble IL-1 receptor type I - AmgenInterleukin-1 receptor type 1 - Amgen
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionImmunosuppressantsInterleukin-1 beta inhibitors
TargetsInterleukin-1 beta
Therapy Area/IndicationsRejection of organ transplantationHypersensitivityGraft vs Host Disease +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAmgen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmgen Inc
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationHypersensitivityGraft vs Host Disease +[6] 

Other Information

ATC CodeN/A
Related LinksN/A